presented at cirse 2020 summit

The results from the CIRSE observational studies on chemo- and radioembolisation have been published exclusively in CVIR!

Not only are these the first-ever published results from CIRSE sponsored studies, but they also represent the largest cohorts on their respective treatments. Read about the outcomes of CIRT, CIRT-FR and CIREL here!

Scientific Societies Should Start Sponsoring Observational Studies 

Philippe L. Pereira, Thomas Helmberger, Julien Taieb, Valérie Vilgrain & Thierry de Baere

The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolisation in Colorectal Cancer Liver Metastases: Interim Analysis

Philippe L. Pereira, Roberto Iezzi, Riccardo Manfredi et al.

Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT)

Thomas Helmberger, Rita Golfieri, Maciej Pech et al. 

On behalf of the CIRT Steering Committee & On behalf of the CIRT Principal Investigators

Short-term Safety and Quality of Life Outcomes Following Radioembolization in Primary and Secondary Liver Tumours: a Multi-centre Analysis of 200 Patients in France 

Romaric Loffroy, Maxime Ronot, Michel Greget et al.

On behalf of the CIRT-FR Principal Investigators

The PAD Day was back for a second time at the CIRSE 2020 Summit with session First@CIRSE featuring the latest data releases in the field and an Innovative Forum. Read the reports from the latest study releases:

Prediction Model for Freedom from TLR from a Multi-study Analysis of Long-Term Results with the Zilver PTX Drug-Eluting Peripheral Stent 

Michael D. Dake, Fabrizio Fanelli, Aaron E. Lottes et al.  

Two-Year Efficacy and Safety Results from the IMPERIAL Randomized Study of the Eluvia Polymer-Coated Drug-Eluting Stent and the Zilver PTX Polymer-free Drug-Coated Stent

Stefan Müller-Hülsbeck, Andrew Benko, Yoshimitsu Soga et al.

Clinical Outcomes of Ambulatory Endovascular Treatment Using 4-French and 6-French Femoral Access Strategies: The Bio4amb Multicentre Trial

Marianne Brodmann, Koen Deloose, Eric Steinmetz et al.